Insider Transactions in Q2 2021 at Miromatrix Medical Inc. (MIRO)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Jeffrey James Ross CHIEF EXECUTIVE OFFICER |
BUY
Conversion of derivative security
|
Direct |
4,400
+50.0%
|
-
|
|
Jun 28
2021
|
Brian Niebur CHIEF FINANCIAL OFFICER |
BUY
Conversion of derivative security
|
Direct |
6,668
+41.67%
|
-
|
|
Jun 28
2021
|
John L Erb |
BUY
Conversion of derivative security
|
Direct |
6,667
+35.3%
|
-
|
|
Jun 28
2021
|
Paul Buckman |
BUY
Conversion of derivative security
|
Indirect |
3,000
+25.96%
|
-
|
|
Jun 28
2021
|
Mark T Wagner Director |
BUY
Conversion of derivative security
|
Direct |
3,334
+50.0%
|
-
|
|
Jun 28
2021
|
Ronald E Eibensteiner Director |
BUY
Conversion of derivative security
|
Indirect |
20,000
+50.0%
|
-
|
|
Jun 28
2021
|
Ronald E Eibensteiner Director |
BUY
Conversion of derivative security
|
Direct |
179,769
+45.02%
|
-
|
|
Jun 28
2021
|
Cheshire Md Holdings, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,980,091
+42.29%
|
-
|
|
Jun 24
2021
|
Baxter International Inc > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,083,333
+50.0%
|
-
|
|
Jun 23
2021
|
John L Erb |
BUY
Grant, award, or other acquisition
|
Direct |
5,555
+50.0%
|
-
|
|
Jun 23
2021
|
Paul Buckman |
BUY
Grant, award, or other acquisition
|
Direct |
5,555
+50.0%
|
-
|
|
Jun 23
2021
|
Peter Maag |
BUY
Grant, award, or other acquisition
|
Direct |
22,221
+46.43%
|
-
|